Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says

Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.

Rebecca Robbins
Author: Rebecca Robbins

Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.